Live feed
Filing
SC 13G/A
SC 13G/A0000947871-22-000219·ORBIMED ADVISORS LLC
Schedule 13G ownership disclosure
X4 PHARMACEUTICALS INC
Security class unavailable · CUSIP: 98420X103
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-22-000219
- Form type
- SC 13G/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Feb 11, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership